Insider holders · CIK 0001731831
Eidos Therapeutics, Inc. · EIDX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| BridgeBio Pharma LLC10% Owner | 22,589,300 | — | 22,589,300 | Dec 13, 2018 · 6:14 pm EST | Form 4/A |
| Neil KumarChief Executive Officer | — | 22,589,300 | 22,589,300 | Feb 14, 2019 · 6:19 pm EST | Form 5 |
| Ali J. SatvatDirector | — | 22,589,300 | 22,589,300 | Feb 14, 2019 · 6:24 pm EST | Form 5 |
| Rajeev M. ShahDirector | — | 2,162,671 | 2,162,671 | Jun 22, 2018 · 7:00 pm EDT | Form 4 |
| Peter Kolchinsky10% Owner | — | 2,162,671 | 2,162,671 | Jun 22, 2018 · 7:33 pm EDT | Form 4 |
| RA CAPITAL MANAGEMENT, LLCDirector | — | 2,162,671 | 2,162,671 | Jun 22, 2018 · 7:33 pm EDT | Form 4 |
| RA Capital Healthcare Fund LP10% Owner | — | 2,162,671 | 2,162,671 | Jun 22, 2018 · 7:33 pm EDT | Form 4 |
| Jonathan C FoxSee Remarks | — | 536,527 | 536,527 | Jun 19, 2018 · 9:36 pm EDT | Form 3 |
| Uma SinhaChief Scientific Officer | 353,231 | — | 353,231 | Jun 19, 2018 · 9:34 pm EDT | Form 3 |
| Cameron TurtleChief Business Officer | 107,305 | — | 107,305 | Nov 7, 2018 · 7:06 pm EST | Form 3 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.